AMD is the leading cause of vision loss over 50. AMD stands for "Age-related Macular Degeneration". It is how our eyes age. AMD affects the center of the retina, called "the macula", where vision is focused and sharpest. AMD does not cause blindness. However, AMD can cause "legal blindness", vision so blurry that you are unable to read, drive, or recognize faces. This can happen slowly, or suddenly. Studies show that nothing reduces this risk better than Vision Protection Therapy.
That number is growing daily. Vision loss from AMD is the major cause of loss of independence and decreased quality of life for people over 50 worldwide, and a major burden on affected patients and their families. AMD is one of the most important unmet healthcare needs in the modern world.
The earliest form of AMD is called “dry” AMD. People with early dry AMD have good vision on the eye chart but may have difficulty seeing at night and indoors. Driving at night can become difficult. Adjusting to a bright or dark room may take longer than usual. Reading a restaurant menu may become impossible without a flashlight.
Only about 10% of people with AMD develop severe vision loss due to dry AMD. This occurs when a condition called “geographic atrophy” (GA) develops. GA leaves an atrophic, or “dead spot” in the center of the retina that gets bigger with time. The bigger the GA spot gets, the more vision that is lost. While dry AMD usually progresses slowly over many years, GA progresses more rapidly. Eventually, the ability to read, drive and see faces is lost. Published studies show that Vision Protection Therapy is both the safest and most effective way to slow progression of GA.
Wet AMD is the main cause of vision loss from AMD. In fact, 90% of people who lose vision from AMD lose vision when they develop “wet” AMD. This means that the best way to prevent vision loss from AMD is to prevent the development of wet AMD. Nothing does this better than Vision Protection Therapy.
In wet AMD, scar tissue, called “neovascularization” develops in the macula. This scar tissue grows, destroying the macula and the sharp vision. Things you look directly at may be blurry and distorted, or wavey. To others, it is like looking through Swiss cheese, with holes in their vision. When wet AMD develops, the ability to drive, read and recognize faces may be lost. This can happen suddenly, and without warning.
AMD vision loss is often permanent and progressive, even with current treatments. To make matters worse, once you lose vision in one eye from AMD, you are at increased risk for eventually losing vision in your good eye as well. The answer? Prevention
In two large national real-world data studies, eyes with wet AMD given Vision Protection Therapy in addition to drug injections needed up to 4.5 X fewer eye injections with better vision results than injections alone. This is because VPT makes the injections work better: when they work better, they last longer, and fewer injections are needed. This is important for several reasons: (1) who likes eye injections? (2) these drugs are very expensive (3) there are risks from the injections that, although rare, can be very serious, and (4) the anti-VEGF drugs in the injections cause geographic atrophy or make it worse, leading to worse vision in the long-run. Thus, while eye injections are essential for wet AMD, reducing them with Vision Protection Therapy has clear benefits.
Vision Protection Therapy is the most effective treatment to reduce your risks of vision loss from AMD ever developed. Vision Protection Therapy is evidence-based, data-driven, innovative, and the only treatment for all types and stages of AMD, wet or dry. We want you to know about it.
Reach out to Vision Protection today to learn more about protecting your vision from AMD. We are standing by to help.
All Rights Reserved | Vision Protection
* Individual results may vary, testimonials are not claimed to represent typical results. All testimonials are from real patients, but are not intended to represent or guarantee that anyone will achieve the same or similar results.